IngredientsMitchella repens (commonly known as partridge berry or squaw vine) is the best-known plant in the genus Mitchella. It is a creeping, prostrate herbaceous woody shrub occurring in North America, belonging to the madder family (Rubiaceae). It is one of the many species first described by Carl Linnaeus, and its species name is the Latin adjective repens, meaning "creeping."
Common names for Mitchella repens in English include partridge berry, squaw vine, twin berry, two-eyed berry, running box, checker berry, and tea berry. In aboriginal languages, it is known as binemiin, binemin, and binewimin in Ojibwe, noon-yeah-ki'e oo-nah'yea in Onondaga, and fiːtó imilpá in Koasati (Coushatta). Additional English synonyms recorded in herbal literature include checkerberry, deerberry, hive vine, one-berry, squaw berry, twinberry, two-eyed berry, and winter clover.
The partridge berry is an evergreen plant growing as a non-climbing vine, no taller than 6 cm tall, with creeping stems 15 to 30 cm long. It belongs to the Rubiaceae family and grows in woodland habitats, producing small white flowers and red berries. It grows in the forests and woodlands of the eastern United States and Canada, and is usually found at the base of trees and stumps.
The twinned, tubular flowers of this distylous plant are bright white and produce volatile organic compounds (VOCs). Partridgeberry has intermorph incompatibility and thus requires pollinators to move pollen from one morph to the other. A 2024 study using headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography–mass spectrometry (GC–MS) analysis identified the floral VOC profile; the four predominant molecules were α-pinene, camphene, D-limonene, and verbenone, and the overall VOC profile contained 27 molecules consisting mostly of monoterpenes.
Although squawvine grows year round, herbalists recommend collecting the herb when the plant flowers during the months of April through June.
The leaves, stems, and berries of the plant are used medicinally, particularly in traditional women's health formulas. Squawvine is available in various forms; commercial preparations include tinctures, extracts, and powdered herb.
Squawvine is also referred to as "partridge berry" because some people consider the name "squawvine" to be insulting to Native American women. The term "squaw" in squawvine is an outdated reference to Indigenous women, as the plant was traditionally entrusted to female healers and midwives.
This herb has a long-standing reputation in traditional herbal medicine, particularly among Indigenous peoples and early American settlers. Historically, squaw vine was widely valued for its ability to support women's reproductive health. Native American women used it as a gentle tonic during pregnancy, believing it could promote easier childbirth.
Traditionally, the plant had numerous medicinal uses including as a diuretic (by the Cherokee and Iroquois), a diaphoretic (Cherokee), for women's problems or reproductive issues (Cherokee, Delaware, Iroquois), and as an analgesic or to reduce fever or swelling. In the tradition of the Iroquois, squaw vine is used as a "love medicine" as well as for treating venereal diseases, while the Ojibwa smoke the leaves during ceremonies.
The plant was used to ease menstrual cramps, strengthen the uterus for childbirth, and prevent miscarriage. During the final 2 to 4 weeks of a Native American woman's pregnancy, she drank tea made from squawvine leaves so that childbirth was less painful. The herb was said to regulate contractions so that the baby was delivered safely, easily, and quickly. After the baby was born, the Native American mother who nursed her child would put a squawvine solution on her nipples to relieve the soreness.
Externally, squawvine has been applied as a poultice for swellings and sore nipples. A steam bath can be prepared to treat stiff, rheumatic joints. Native Americans have also used it to treat various feverish conditions.
European settlers adopted squawvine into Eclectic medicine, the 19th-century botanical system of healthcare practiced in North America. Eclectic physicians praised it as a parturient herb, useful in the final weeks of pregnancy to tone the uterus and ease labor.
After a long history as a uterine tonic by North America's indigenous population, partridge berry was adopted by the Eclectic Physicians, who administered it to susceptible women to prevent miscarriage and to prepare for labour, noting its use "will often favour a mild and speedy delivery."
This tradition was embraced by 19th-century herbalists, who recommended squaw vine as part of "partus preparator" teas designed to tone the uterus and prepare the body for labor. King's American Dispensatory (1873) recorded squawvine as a parturient and also noted indications for dysmenorrhea, menorrhagia, and described its use as a diuretic and astringent. The King's American Dispensatory (as preserved in Eclectic sources) describes partridgeberry as parturient, diuretic, and astringent, used in dropsy, suppression of urine, and diarrhoea; it was felt to have "an especial affinity for the uterus, exerting a powerful tonic and alterative influence," and was found beneficial in amenorrhoea, some forms of dysmenorrhoea, menorrhagia, and chronic congestion of the uterus.
In folk medicine, squawvine continued to be a remedy for women's disorders. In addition to conditions related to childbirth, the herb was used to treat postpartum depression, irregular menstruation, and bleeding. A squawvine wash was said to provide relief to sore eyes.
Squawvine is still used in folk medicine to treat conditions including anxiety, hemorrhoids, insomnia, muscle spasms, edema, and inflammation. People have also taken squawvine for water retention (edema), low urine output, varicose veins, sleep problems (insomnia), congestive heart failure, kidney failure, liver failure, severe diarrhea (chronic dysentery), and colitis. Women have taken it for treating menstrual disorders, fibrocystic breast disease, and vaginal discharges, as well as to ease childbirth, treat depression after childbirth, and improve the flow of breast milk.
Reported constituents of the aerial parts of Mitchella repens include tannins, saponins, a bitter principle, alkaloids, and mucilages. The 19th-century chemist E. Breneiser (writing in the American Journal of Pharmacy, 1887) found the plant to contain some resin, wax, mucilage, dextrin, and what appeared to be saponin. The water-soluble part of an ether extract of the plant contained a principle forming a precipitate with tannic acid and with picric acid, but it was neither a classical alkaloid nor a glucoside.
According to a compilation citing NIH-indexed literature, Mitchella repens contains resin, wax, dextrin, saponins, alkaloids, glycosides, and tannins. Several bioactive constituents, including glycosides, tannins, and saponins, are thought to contribute to its traditional applications.
The plant's floral profile adds further phytochemical complexity. The floral volatile organic compounds identified by GC-MS include the four predominant molecules α-pinene, camphene, D-limonene, and verbenone, with an overall VOC profile containing 27 molecules consisting mostly of monoterpenes.
Regarding the mechanism by which saponins may contribute to uterine activity, one laboratory study proposed that it is likely that the saponin constituent contained within the applied extract is involved with the muscle contractions.
The most studied putative mechanism of squawvine is its potential oxytocic (uterine-contracting) effect. Aqueous extracts of M. repens applied at concentrations of 0.19 mg/ml, 0.375 mg/ml, 0.75 mg/ml, and 1.44 mg/ml produced uterine contractile responses statistically greater than the tissue's own spontaneous motility (p < 0.0001). These contractions were also statistically more forceful than the tissue's own spontaneous motility (p < 0.0001). The postulated mechanism involves saponin-mediated membrane effects on smooth muscle cells.
The plant appears to be diuretic, tonic, and astringent, resembling in these respects the pipsissewa, for which it is sometimes substituted. The tannin content is proposed to underlie astringent properties attributed to the plant. Tannins are polyphenols known to precipitate proteins and can thereby contribute to antimicrobial and tissue-tightening effects, as documented broadly in the botanical medicine literature.
A study used X-band (9.3 GHz) electron paramagnetic resonance (EPR) spectroscopy to examine the free radical scavenging activity of infusions, including Mitchella repens herb, that were nonirradiated and exposed to UVA. The infusion of Mitchella repens herb interacts with free radicals, albeit in the slowest way among the medicinal plants tested for obstetric use. This indicates measurable but comparatively modest antioxidant activity in aqueous infusion.
Mitchella repens herb has been reported to have sedative and diuretic effects in references in the obstetrics literature. These properties are described in traditional and ethnobotanical accounts but have not been confirmed in controlled human clinical trials.
Evidence level: Preclinical (in vitro) only; no human clinical trials.
Mitchella repens has a long history of effective treatments for a number of female reproductive concerns including the maintenance of a healthy pregnancy, readiness for labor, and successful labor itself. Documentation for its use comes primarily through traditional medicine and midwifery. Very little empirical research has validated the efficiency of such claims.
The primary experimental study supporting a uterine mechanism was published in the Journal of Medicinal Plants Studies (2021) by Horner and DeGolier. The specific objective of this project was to determine whether Mitchella repens demonstrated oxytocic activities in uterine tissues. Increasing concentrations of aqueous extracts of Mitchella repens were applied directly to isolated mouse uterine horns suspended in an organ bath. Results showed that Mitchella repens produced strong contractile responses that were greater than the tissue's own spontaneous motility (p < 0.0001), and on average were 80.45% of their own oxytocin positive control.
The results of this study provide some empirical support for the claim that Mitchella repens can augment labor contractions and/or potentially induce labor. However, this was an in vitro animal tissue study, not a human clinical trial. Results from isolated mouse uterine strips cannot be directly extrapolated to human clinical outcomes.
A second in vitro study (Neuenschwander et al., Pharmacognosy Journal, 2021) examined a midwifery herbal induction tincture. Cramp bark (Viburnum opulus), partridgeberry (Mitchella repens), and motherwort (Leonurus cardiaca) were each prepared as aqueous extracts and applied individually to uterine tissues in an organ bath apparatus. Results indicated that all treatment tissues produced significant increases in contractile forces when compared to their own endogenous motilities (p < 0.0001). These responses, however, were not significantly different among the four herbal treatments, but were comparable to those produced by 10⁻⁵ M oxytocin.
Despite its established place in folk medicine and early herbalist texts (including the Eclectic physicians of the 19th century), there is a lack of modern scientific studies or clinical trials to substantiate these claims. No active constituents in squaw vine have been conclusively shown to affect pregnancy outcomes in humans, and safety data is insufficient.
Evidence level: Traditional use only; no controlled human clinical studies identified.
Herbalists and naturopathic sources describe Mitchella repens as a uterine tonic that tonifies the mucous membrane of the uterus gently over a long period of time (greater than 3 cycles), and it is reportedly helpful in dysmenorrhea and PMS. Women have taken it for treating menstrual disorders including fibrocystic breast disease and vaginal discharges. No published randomized controlled trials in humans have evaluated squawvine specifically for these indications.
Evidence level: In vitro laboratory study only.
A peer-reviewed study aimed to compare the free radical scavenging ability of tested obstetric plant infusions and to determine the influence of UVA irradiation of the plant materials on interactions of these infusions with free radicals. Both the magnitude and kinetics of the interactions of the infusions with the model DPPH free radicals were examined. The infusion of Mitchella repens herb interacts with free radicals in the slowest way among the tested plant materials. UVA radiation reduces the antioxidant interactions of all tested infusions. This study did not evaluate clinical outcomes in humans.
Evidence level: Traditional/historical use only; no clinical trial data.
Extracts of Mitchella repens herb are typically used in the puerperium to alleviate nipple swelling and pain, and in the burn of the breasts. Squawvine has also been taken to improve the flow of breast milk and treat depression after childbirth. These uses are documented in ethnobotanical and traditional herbal literature but lack clinical trial support.
Evidence level: Traditional/ethnobotanical use only; one animal study reference exists but human clinical data are absent.
The Cherokee and Iroquois used the plant as a diuretic. Squaw vine is described as diuretic and anti-inflammatory and has been used in various urinary conditions such as urethritis, prostatitis, and painful urination. Diuretic effects are reported in references within the obstetrics literature, but human clinical trial data are not available.
Evidence level: Traditional use only; no human clinical trials.
Squawvine is said to have a calming effect on the nervous system; it may be used in nervous exhaustion, irritability, or debility in either sex, especially when symptoms involve the reproductive system. Squawvine is still used in folk medicine to treat anxiety and insomnia. There are no published human clinical studies evaluating these effects.
Evidence level: Traditional use only; no clinical trials.
In Eclectic medicine, squawvine was used in dropsy, suppression of urine, and diarrhea in decoction. Folk use includes taking squawvine for diarrhea and chronic dysentery. No human studies have evaluated this application.
Despite its traditional use, there is a lack of robust scientific research validating these claims. For all conditions beyond traditional or ethnobotanical documentation, more evidence is needed to rate the effectiveness of squawvine. The existing evidence base consists almost entirely of (1) ethnobotanical records of Indigenous and Eclectic use, (2) two in vitro organ-bath studies on isolated mouse uterine tissues, and (3) one in vitro antioxidant characterization. No human randomized controlled trials, systematic reviews, or controlled observational studies have been published evaluating squawvine for any indication.
Squawvine is available in various forms; commercial preparations include tinctures, extracts, and powdered herb. Squawvine tea (infusion) is made by pouring 1 cup (240 ml) of boiling water over 1 tsp (1.5 g) of the dried herb. The mixture is steeped for 10 to 15 minutes and then strained. Squawvine tea may be taken up to three times a day.
Naturopathic herbal reference sources document the following preparations: Infusion: ½ tsp per cup water, 3–4 cups three times daily; Tincture (1:5, 25% ethanol): 5–10 ml three times daily; Fluid Extract (1:1, 25% ethanol): 2–4 ml three times daily; also used as a douche in infusion form.
Tincture dosage has also been reported as 1–2 mL in 1 cup (240 ml) of boiling water, taken three times a day.
One herbalist preparation guide recommends pouring 1 cup of boiling water onto 1 teaspoon of the herb and steeping for 10–15 minutes, to be drunk three times per day; tincture dosage is listed as 1–2 ml three times per day.
The appropriate dose of squawvine depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for squawvine. All dosages above are derived from traditional herbal practice, not from controlled clinical studies, and no evidence-based dose has been established.
Squawvine seems safe for most people when taken by mouth in appropriate amounts. Historical naturopathic references note no toxicity reported. However, the overall safety evidence base is sparse and primarily derived from traditional use records rather than clinical safety studies.
Extracts of Mitchella repens herb are typically used in the puerperium to alleviate nipple swelling and pain; however, it was stated in the relevant obstetric literature that there are no literature reports about the safety of use of Mitchella repens herb in pregnant women and during lactation.
It is considered unsafe to use squawvine during pregnancy. There is some evidence that it might cause a miscarriage. It is also best to avoid squawvine if breastfeeding, as not enough is known about how it might affect the nursing infant.
This warning reflects the herb's known uterine-contracting properties, supported by in vitro data. Results from the organ bath study showed that Mitchella repens produced contractile responses that on average were 80.45% of their own oxytocin positive control — a magnitude that raises plausible concern about uterotonic activity at clinically relevant doses. Some herbal sources advise: do not use during pregnancy except during labour.
The historical record also documents abortifacient use. Squawvine has also been used to cause abortions. Native American women may also have used this herb to terminate unwanted pregnancies.
There is insufficient information to know whether squawvine can be safely used on the skin.
No specific herb–drug interaction studies for Mitchella repens have been identified in peer-reviewed literature. Given its proposed uterotonic mechanism involving saponin-mediated effects on smooth muscle, theoretical interactions with oxytocin or other uterotonic agents are plausible but unconfirmed. No interaction data with anticoagulants, sedatives, or other drug classes have been documented in the available scientific literature for this specific herb.
Despite its established place in folk medicine and early herbalist texts, no active constituents in squaw vine have been conclusively shown to affect pregnancy outcomes in humans, and safety data is insufficient. The absence of clinical safety data means that characterization of the full adverse effect profile, contraindications, and drug interactions of squawvine remains incomplete.
Health conditions that Squawvine may help support.
Squawvine is listed in folk medicine sources as a traditional remedy for anxiety and nervous exhaustion, attributed to its mild sedative and nervine tonic properties. Eclectic texts describe it as a nervous tonic and restorative for irritability and debility. No clinical evidence exists.
Squawvine is documented in folk medicine and traditional herbal practice for improving the flow of breast milk and for topical relief of sore nipples. RxList and encyclopedia sources record these traditional uses. No clinical evidence supports galactagogue or nipple-care efficacy.
Squawvine is classified in Eclectic and naturopathic herbal tradition as a nervous tonic and mild sedative, indicated for nervous exhaustion, irritability, and debility. Multiple herbal sources document its calming effect on the nervous system. No clinical trials exist.
Squawvine is listed in Eclectic herbal tradition and folk medicine as indicated for catarrhal colitis. The tannin-based astringent action on inflamed mucous membranes provides a plausible traditional rationale. No clinical studies have been conducted.
Squawvine was used by the Cherokee people for dysentery and diarrhea, documented in ethnobotanical records. Its tannin-rich phytochemical profile provides a mechanistic rationale for astringent anti-diarrheal activity. Multiple traditional herbal sources confirm this use.
Squawvine has documented traditional use as a tonic to support female fertility, particularly by toning the uterus and ovaries over several menstrual cycles. It appears in ethnobotanical records and naturopathic herbal texts as an adjunct for infertility related to uterine weakness or hormonal irregularity. No human clinical evidence exists.
Squawvine is listed in folk medicine references as a remedy for hemorrhoids, consistent with its documented astringent and anti-inflammatory properties from tannin-rich constituents. Traditional herbal practice also combined it with witch hazel for bleeding piles. No clinical evidence exists.
The Menominee people of North America specifically used squawvine leaves in a drink to treat insomnia, as recorded in ethnobotanical literature. The herb is also noted in folk medicine for sedative effects attributed to its phytochemical constituents. No clinical trials exist.
Squawvine is documented in traditional herbalism as an emmenagogue and menstrual regulator. Naturopathic and Eclectic sources identify it for regulating the menstrual cycle over a period of several months of consistent use. No clinical evidence exists.
Squawvine has a well-documented traditional use for dysmenorrhea across Native American tribes and in Eclectic and naturopathic medicine. It is classified as an antidysmenorrhoeic and uterine relaxant. The tannins and saponins in the plant are proposed to contribute to smooth-muscle-relaxing and anti-inflammatory actions. No human clinical studies exist.
Traditional and naturopathic herbalism documents squawvine for PMS, particularly the type accompanied by water retention, pelvic congestion, and irritability. Its combined diuretic, uterine-tonic, and mild nervine properties are cited as the basis. No clinical trials exist.
Squawvine has well-documented traditional use in the postpartum period: topically for sore nipples, internally for postpartum uterine recovery, and in folk medicine for postpartum depression and menstrual restoration. Native American midwifery practice and Eclectic medicine both document these uses. No clinical trials exist.
Squawvine is noted in traditional herbal and folk medicine sources as a tonic for the prostate and for use in benign prostatic hyperplasia (BPH). RxList, encyclopedia sources, and Chestnut School of Herbal Medicine document this use. No clinical evidence exists.
Squawvine's use as a diuretic by the Cherokee and Iroquois and its mild anti-inflammatory properties have generated a traditional application for urinary tract conditions including UTIs and interstitial cystitis. Multiple herbal sources document this use. No clinical trials exist.
Squawvine has one of its most deeply rooted traditional applications as a uterine tonic. Native American women, particularly among the Cherokee, Iroquois, Delaware, and other Eastern Woodland tribes, used it to strengthen the uterus and prepare for childbirth. Eclectic physicians of the 19th century adopted it as a 'partus preparator.' No controlled clinical trials have validated these uses.
Squawvine has a documented traditional use for leukorrhea (pathological vaginal discharge) in both Eclectic medicine and naturopathic herbalism, attributed to its astringent tannin content acting on vaginal mucosa. RxList also records use for vaginal discharges. No clinical evidence exists.
Squawvine is documented as a traditional diuretic used by the Cherokee and Iroquois, and multiple folk medicine sources list it for edema and water retention. Pharmacobotanical references attribute diuretic properties to the plant's glycoside constituents. No clinical studies exist.
Body systems that Squawvine may help support.
Go back